Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial page displays the record for a Phase 2 study of cabozantinib in people with refractory soft tissue sarcoma, including study details, results measures, and supporting documents, rather than an access-denied error.SummaryDifference62%

- Check13 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH website transition updates and says some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe revision label in the footer changes from v3.7.0 to v3.7.1; the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study details page now displays a 403 Forbidden page, replacing the previous content. This blocks access to the study record and its details.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.